157 related articles for article (PubMed ID: 32968137)
21. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma.
Rübben A; Kempf W; Kadin ME; Zimmermann DR; Burg G
Exp Dermatol; 2004 Aug; 13(8):472-83. PubMed ID: 15265011
[TBL] [Abstract][Full Text] [Related]
22. Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.
Hamrouni A; Fogh H; Zak Z; Ødum N; Gniadecki R
Clin Cancer Res; 2019 May; 25(10):3104-3114. PubMed ID: 30808775
[TBL] [Abstract][Full Text] [Related]
23. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
25. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
Wong HK
G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
27. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.
Hsi AC; Lee SJ; Rosman IS; Carson KR; Kelley A; Viele V; Pang X; Musiek A; Schaffer A
J Am Acad Dermatol; 2015 Jan; 72(1):159-67. PubMed ID: 25440432
[TBL] [Abstract][Full Text] [Related]
28. Lichen sclerosus with histopathologic features simulating early mycosis fungoides.
Citarella L; Massone C; Kerl H; Cerroni L
Am J Dermatopathol; 2003 Dec; 25(6):463-5. PubMed ID: 14631186
[TBL] [Abstract][Full Text] [Related]
29. Granulomatous variants of cutaneous T-cell lymphoma. The histopathology of granulomatous mycosis fungoides and granulomatous slack skin.
LeBoit PE; Zackheim HS; White CR
Am J Surg Pathol; 1988 Feb; 12(2):83-95. PubMed ID: 3257655
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous lymphomas other than mycosis fungoides.
Gilliam AC; Wood GS
Semin Oncol; 1999 Jun; 26(3):290-306. PubMed ID: 10375086
[TBL] [Abstract][Full Text] [Related]
31. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
32. The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation.
Iliadis A; Koletsa T; Patsatsi A; Georgiou E; Sotiriadis D; Kostopoulos I
Eur J Dermatol; 2016 Dec; 26(6):566-571. PubMed ID: 27545221
[TBL] [Abstract][Full Text] [Related]
33. Various skin manifestations of mycosis fungoides: histopathological features and prognosis.
Koga M; Imafuku S; Nakayama J
Fukuoka Igaku Zasshi; 2011 Jul; 102(7):229-36. PubMed ID: 21879593
[TBL] [Abstract][Full Text] [Related]
34. Mycosis fungoides and Sézary syndrome tumor cells express epidermal fatty acid-binding protein, whose expression decreases with loss of epidermotropism.
Takahashi-Shishido N; Sugaya M; Morimura S; Suga H; Oka T; Kamijo H; Miyagaki T; Sato S
J Dermatol; 2021 May; 48(5):685-689. PubMed ID: 33560534
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
36. Unilesional Follicular Mycosis Fungoides: Report of 6 Cases and Review of the Literature.
Magro CM; Telang GH; Momtahen S
Am J Dermatopathol; 2018 May; 40(5):329-336. PubMed ID: 29135509
[TBL] [Abstract][Full Text] [Related]
37. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides.
Nickoloff BJ
Am J Dermatopathol; 1988 Dec; 10(6):469-77. PubMed ID: 3064629
[TBL] [Abstract][Full Text] [Related]
38. The intracutaneous growth of murine lymphomas: epidermal invasion is characteristic of multiple tumor phenotypes.
Piepkorn M; Tigelaar RE
J Invest Dermatol; 1984 Oct; 83(4):281-5. PubMed ID: 6237158
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
40. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
